{"id":"W3023738757","doi":"10.1016/s1470-2045(20)30061-9","title":"Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Manchester Biomedical Research Centre; Clovis Oncology; Memorial Sloan-Kettering Cancer Center; Stand Up To Cancer; Entertainment Industry Foundation; V Foundation for Cancer Research; University College London; American Association for Cancer Research","keywords":"Placebo; Medicine; Oncology; Internal medicine; Ovarian carcinoma; Ovarian cancer; Cancer; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007392996,0.0003036253,0.00158855,0.00005027946,0.0002112881,0.00002629036,0.0001391361,0.0002009151,0.0000852946],"category_scores_gemma":[0.0009917811,0.000171834,0.0001465478,0.0001365496,0.0002268333,0.00006914426,0.00005508551,0.000398274,0.000008376133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001609122,"about_ca_system_score_gemma":0.0003045501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005599728,"about_ca_topic_score_gemma":0.00003535869,"domain_scores_codex":[0.9974719,0.0005562257,0.0007583314,0.0005234265,0.0002903815,0.0003997186],"domain_scores_gemma":[0.996346,0.002203423,0.0005613186,0.0003727097,0.0002957323,0.0002208462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.979189,0.0005097961,0.001185177,0.00001852905,0.000446256,0.00002874019,0.002092366,0.00000379825,0.0004275811,0.00009376711,0.005989914,0.01001505],"study_design_scores_gemma":[0.9595513,0.01196695,0.004047528,0.00006977442,0.0004528667,0.000008262092,0.0001869331,0.001003664,0.0003624383,0.00007632558,0.02206791,0.0002059935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9454061,0.0001087845,0.0005585403,0.0411601,0.0006333254,0.008467938,0.002356452,0.0001045629,0.001204182],"genre_scores_gemma":[0.9856491,0.00003978945,0.002833038,0.007347767,0.001318756,0.000602667,0.002119391,0.00003915321,0.00005031172],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04024301,"threshold_uncertainty_score":0.7007187,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04068493652222073,"score_gpt":0.3485534876066515,"score_spread":0.3078685510844308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}